168 related articles for article (PubMed ID: 37653796)
1. Association among VKORC1 rs9923231, CYP4F2 rs2108622, GGCX rs11676382 polymorphisms and acute ischemic stroke.
Iluţ S; Vesa ŞC; Văcăraş V; Şipoş-Lascu D; Bârsan C; Pop RM; Crişan S; Macarie AE; Coadă CA; Perju-Dumbravă L; Muresanu DF; Buzoianu AD
Medicine (Baltimore); 2023 Aug; 102(34):e34836. PubMed ID: 37653796
[TBL] [Abstract][Full Text] [Related]
2.
Vesa SC; Vlaicu SI; Vacaras V; Crisan S; Sabin O; Pasca S; Trifa AP; Rusz-Fogarasi T; Sava M; Buzoianu AD
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32698322
[TBL] [Abstract][Full Text] [Related]
3. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
[TBL] [Abstract][Full Text] [Related]
4. Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.
Krishna Kumar D; Shewade DG; Loriot MA; Beaune P; Balachander J; Sai Chandran BV; Adithan C
Eur J Clin Pharmacol; 2014 Jan; 70(1):47-56. PubMed ID: 24019055
[TBL] [Abstract][Full Text] [Related]
5. Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study.
Sridharan K; Al Banna R; Malalla Z; Husain A; Sater M; Jassim G; Otoom S
Pharmacol Rep; 2021 Oct; 73(5):1405-1417. PubMed ID: 33811620
[TBL] [Abstract][Full Text] [Related]
6. Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients.
Wakamiya T; Hokosaki T; Tsujimoto S; Kadota K; Nakano Y; Watanabe S; Iwamoto M; Yanagimachi M; Ito S
Mol Diagn Ther; 2016 Aug; 20(4):393-400. PubMed ID: 27262824
[TBL] [Abstract][Full Text] [Related]
7. An acenocoumarol dosing algorithm exploiting clinical and genetic factors in South Indian (Dravidian) population.
Krishna Kumar D; Shewade DG; Loriot MA; Beaune P; Sai Chandran BV; Balachander J; Adithan C
Eur J Clin Pharmacol; 2015 Feb; 71(2):173-81. PubMed ID: 25519826
[TBL] [Abstract][Full Text] [Related]
8. Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients.
Elkhazraji A; Bouaiti EA; Boulahyaoui H; Nahmtchougli CP; Zahid H; Bensaid M; Ibrahimi A; Messaoudi N
Drug Discov Ther; 2018; 12(2):68-76. PubMed ID: 29760340
[TBL] [Abstract][Full Text] [Related]
9. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients.
Wattanachai N; Kaewmoongkun S; Pussadhamma B; Makarawate P; Wongvipaporn C; Kiatchoosakun S; Vannaprasaht S; Tassaneeyakul W
Eur J Clin Pharmacol; 2017 Aug; 73(8):973-980. PubMed ID: 28550460
[TBL] [Abstract][Full Text] [Related]
10. The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation.
Colàs-Campàs L; Royo JL; Montserrat MV; Marzo C; Molina-Seguín J; Benabdelhak I; Cambray S; Purroy F
Pharmacogenomics J; 2018 Sep; 18(5):652-656. PubMed ID: 29273767
[TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of variability in warfarin response after the dose-titration phase.
Iwuchukwu OF; Ramirez AH; Shi Y; Bowton EA; Kawai VK; Schildcrout JS; Roden DM; Denny JC; Stein CM
Pharmacogenet Genomics; 2016 Nov; 26(11):510-516. PubMed ID: 27632229
[TBL] [Abstract][Full Text] [Related]
12. CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.
Cen HJ; Zeng WT; Leng XY; Huang M; Chen X; Li JL; Huang ZY; Bi HC; Wang XD; He YL; He F; Zhou RN; Zheng QS; Zhao LZ
Br J Clin Pharmacol; 2010 Aug; 70(2):234-40. PubMed ID: 20653676
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of acenocoumarol in patients with extreme dose requirements.
Pérez-Andreu V; Roldán V; López-Fernández MF; Antón AI; Alberca I; Corral J; Montes R; García-Barberá N; Ferrando F; Vicente V; González-Conejero R
J Thromb Haemost; 2010 May; 8(5):1012-7. PubMed ID: 20149073
[TBL] [Abstract][Full Text] [Related]
14. Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes.
Sr K; G B; Jain S; Moorthy N; Manjunath SC; Christopher R
Medicine (Baltimore); 2019 Feb; 98(6):e14365. PubMed ID: 30732170
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in CYP4F2 were significantly correlated with susceptibility to ischemic stroke.
Wu Y; Zhao J; Zhao Y; Huang T; Ma X; Pang H; Zhang M
BMC Med Genet; 2019 Sep; 20(1):155. PubMed ID: 31510945
[TBL] [Abstract][Full Text] [Related]
16. Multiplex pyrosequencing method to determine CYP2C9*3, VKORC1*2, and CYP4F2*3 polymorphisms simultaneously: its application to a Korean population and comparisons with other ethnic groups.
Kim KA; Song WG; Lee HM; Joo HJ; Park JY
Mol Biol Rep; 2014 Nov; 41(11):7305-12. PubMed ID: 25069408
[TBL] [Abstract][Full Text] [Related]
17. Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysis.
Ragia G; Karantza IM; Kelli-Kota E; Kolovou V; Kolovou G; Konstantinides S; Maltezos E; Tavridou A; Tziakas D; Maitland-van der Zee AH; Manolopoulos VG
Drug Metab Pers Ther; 2017 Dec; 32(4):183-190. PubMed ID: 29252193
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction.
Kringen MK; Haug KB; Grimholt RM; Stormo C; Narum S; Opdal MS; Fosen JT; Piehler AP; Johansen PW; Seljeflot I; Berg JP; Brørs O
J Biomed Biotechnol; 2011; 2011():739751. PubMed ID: 21127708
[TBL] [Abstract][Full Text] [Related]
19. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.
Takeuchi M; Kobayashi T; Brandão LR; Ito S
Syst Rev; 2016 Jun; 5(1):105. PubMed ID: 27334984
[TBL] [Abstract][Full Text] [Related]
20. CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis.
Takeuchi M; Kobayashi T; Biss T; Kamali F; Vear SI; Ho RH; Bajolle F; Loriot MA; Shaw K; Carleton BC; Hamberg AK; Wadelius M; Hirono K; Taguchi M; Wakamiya T; Yanagimachi M; Hirai K; Itoh K; Brandão LR; Ito S
Pharmacogenomics J; 2020 Apr; 20(2):306-319. PubMed ID: 31673144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
